WHO ICTRP trial
Compassionate Use of Stannsoporfin in Addition to Phototherapy to Reduce the…
NCT01183988 · NIH Clinical Trials · Recruiting
Key facts
| Trial ID | NCT01183988 |
|---|---|
| Public title | Compassionate Use of Stannsoporfin in Addition to Phototherapy to Reduce the Need for Exchange Transfusions in Term and Near-Term Infants |
| Scientific title | Compassionate Use of Stannsoporfin as an Adjuvant to Phototherapy to Reduce the Need for Exchange Transfusions in Term and Near-Term Infants |
| Primary sponsor | InfaCare Pharmaceuticals Corporation |
| Registry | NIH Clinical Trials |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Neonatal Hyperbilirubinemia;Neonatal Jaundice;Jaundice;Hyperbilirubinemia |
| Interventions | Drug: Stanate® |
| Registration date | Aug 16, 2010 |
| Target size | 50 |
| Secondary IDs | 64,185-99A-3W |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: